The use of companion diagnostic device to detect the status of biomarkers in subjects' biological samples can provide important information for the safety and effectiveness of drug use, including helping to screen out specific populations that benefit from a certain type of drug treatment, identify specific populations at increased risk of serious adverse reactions to a certain type of drug treatment, and adjust doses to improve the safety or effectiveness of a certain type of drug.